Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in acute exacerbation of schizophrenia
jRCT2031220096Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial of cariprazine in schizophrenia (4 arms), sponsored by AbbVie Inc. Primary endpoint: Change in Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) Total Score. Started Sep 2022; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2031220096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220096.